News

Many at-risk Americans either do not know about PrEP or don't have access. Here's why raising awareness is key to ending the ...
Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
WHO recommends twice-yearly injectable lenacapavir for HIV prevention, expanding PrEP options for key populations.
Tamar Braxton has announced a new brand partnership with Gilead Sciences. The music veteran will help educate and raise ...
Long-acting injectable PrEP may improve access, protection and adherence, especially for young people and pregnant women, according to Hasina Subedar, a senior technical advisor at South Africa’s ...
A monthly pill would add to the growing number of choices for HIV preexposure prophylaxis, which is now seen as the best hope ...
The World Health Organization has released new guidelines which, for the first time, recommend the use of an injectable form ...
The investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to ...